The impact of vasculitis on patients' social participation and friendships

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL. 70, 2012, Pages

  Carpenter, Delesha M ^a   Meador, Amy E ^b   Elstad, Emily A ^b   Hogan, Susan L ^c   Devellis, Robert F ^c  

^a UNC Hamner Institute for Drug Safety Sciences   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Friends; Quality of life; Vasculitis

Indexed keywords

ADULT; AGED; ALCOHOL ABSTINENCE; ARTICLE; ATTITUDE TO HEALTH; CONSENSUS; FATIGUE; FEMALE; FRIENDSHIP; HUMAN; INFECTION PREVENTION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL ATTITUDE; SOCIAL ISOLATION; SOCIAL NETWORK; SOCIAL PARTICIPATION; SOCIAL SUPPORT; SYMPTOMATOLOGY; TREATMENT OUTCOME; VASCULITIS;

ADULT; AGED; AGED, 80 AND OVER; COMMUNICATION; COMPREHENSION; COST OF ILLNESS; FEMALE; FRIENDS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNET; LIFE STYLE; MALE; MIDDLE AGED; NORTH CAROLINA; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL PARTICIPATION; SOCIAL SUPPORT; VASCULITIS; YOUNG ADULT;

EID: 84863742600     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BOOMSMA MM, BIJL M, STEGEMAN CA, KALLENBERG CG, HOFFMAN GS, TERVAERT JW: Patients' perceptions of the effects of systemic lupus erythmatosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis. Arthritis Rheum 2002; 47: 196-201.
2. COTCH MF: The socioeconomic impact of vasculitis. Curr Opinion Rheum 2000; 12: 20-3.
3. HERLYN K, REINHOLD-KELLER E, ZEIDLER A et al. Health-related quality of life in primary systemic vasculitides. Arthritis Rheum 1998; 41: S538.
4. HOFFMAN GS, DRUCKER Y, COTCH MF, LOCKER GA, EASLEY K, KWOH K: Wegener's granulomatosis: Patient-reported effects of disease on health, function, and income. Arthritis Rheum 1998; 41: 2257-62.
5. KOUTANTJI M, PEARCE S, HARROLD E: Psychological aspects of vasculitis. Rheumatol 2000; 39: 1173-79.
6. KOUTANTJI M, HARROLD E, LANE SE, PEARCE S, WATTS RA, SCOTT DG: Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 2003; 49: 826-37.
7. NEWALL C, SCHINKE S, SAVAGE CO, HILL S, HARPER L: Impairment of lung function, health status and functional capacity in patients with ANCA-associated vasculitis. Rheumatol 2005; 44: 623-28.
8. REINHOLD-KELLER E, HERLYN K, WAGNERBASTMEYER R, GUTFLEISCH J, PETER HH, GROSS WL: Effect of Wegener's Granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis. Arthritis Rheum 2002; 47: 320-25.
9. THE WEGENER'S GRANULOMATOSIS ETENERCEPT TRIAL RESEARCH GROUP: Etanercept plus standard therapy for Wegener's Granulomatosis. New England J Med 2005; 352: 351-61.
10. THORPE C: Illness Self-management Among Adults Living with ANCA Small Vessel Vasculitis. University of North Carolina at Chapel Hill, 2006.
11. CARPENTER D, THORPE C, LEWIS M, DEVELLIS R, HOGAN S: Health-related quality of life for patients with vasculitis and their spouses. Arthritis Care Res 2009; 61: 259-65.
12. CARPENTER D, KADIS J, DEVELLIS R, HOGAN S, JORDAN J: The effect of medication-related support on the quality of life of patients with vasculitis in relapse and remission. J Rheumatol 2011; DOI:10.3899/jrheum.100808.
13. FAURSCHOU M, SIGAARD L, BJORNER J, BASLUND B: Impaired Health-related Quality of Life in Patients Treated for Wegeners Granulomatosis. J Rheumatol 2010; 37: 2081-5.
14. PENNINX B, KRIEGSMAN D, VAN EIJK J, BOEKE A, DEEG D: Differential effect of social support on the course of chronic disease: a criteria-based literature study. Fam Syst & Health 1996; 14: 223-44.
15. JERROME D: Frailty and friendship. J Cross-Cultural Gerontol 1990; 5: 51-64.
16. CARPENTER DM, DEVELLIS RF, HOGAN SL, FISHER EB, DEVELLIS BM, JORDAN JM: The effect of conflicting medication information and physician support on medication adherence for chronic disease patients. Patient Educ Couns 2009.
17. MUHR T: ATLAS.ti [Version 5.1]. Berlin, Germany: ATLAS.ti Scientific Software Development GmbH. 2004. Available from http://www.atlasti.com/.
18. HAJJ-ALI RA, WILKE WS, CALABRESE DO et al. A pilot study to assess the frequency of fibromyalgia, depression and sleep disorders in patients with Wegener granulomatosis. Arthitis Care Res; epub ahead of print: DOI 10.1002/acr.20442.
19. HERLYN K, HELLMICH B, SEO P, MERKEL PA: Patient-reported outcome assessment in vasculitis provides important data and a unique perspective. Arthritis Care Res 2010; 62: 1639-45.
20. BASU N, JONES G, FLUCK N et al. Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology 2010; 49: 1383-90.
21. LASKER JN, SOGOLOW ED, SHARIM RR: The role of an online community for people with a rare disease: content analysis of messages posted on a primary biliary cirrhosis mailinglist. J Medical Internet Res 2005; 7: e10.
22. JOACHIM G, ACORN S: Life with a rare chronic disease: the scleroderma experience. J Adv Nurs 2003; 42: 598-606.
23. LIANG M, ROGERS M, LARSON M et al. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1984; 27: 13-9.
24. FITZPATRICK R, NEWMAN S, LAMB R, SHIPLEY M: Social relationships and psychological well-being in rheumatoid arthritis. Social Sci Med 1988; 27: 399-403.
25. GOODENOW C, REISINE S, GRADY K: Quality of social support and associated social and psychological functioning in women with rheumatoid arthritis. Health Psychol 1990; 9: 266-84.